The incidence of Alzheimer’s disease is increasing worldwide. The need to fortify global resources conducting clinical trials becomes of paramount importance for sponsors to ensure less delay in marketing their products. This chapter provides a concise and practical approach to building capacity and capability in emerging or developing markets. Lessons learned from countries like China and India, where the top 12 pharmaceutical and biotech companies have become deeply entrenched in the last 10 years, serve as important benchmarks which can be referenced as new emerging markets like Vietnam, Indonesia, and the Philippines establish themselves as available and capable areas for clinical trials. Referenced case studies describe actual events from which valuable practical pearls can be adapted in other settings. Sponsors need to recognize that investing early on in developing project teams that can support these trials creates a better landscape for success.